Request that FDA declare that Ibuprofen Oral Suspension, 200 mg/5 mL, is suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-5975
Documents
6
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
Supporting & Related MaterialMay 27, 2026
Attachment 1